RazorMetrics Achieves Surescripts® Clinical Direct Messaging Certification

Enhancing Provider Communication with Seamless Cost-Saving Medication Alerts

AUSTIN, Texas, March 25, 2025 /PRNewswire/ — RazorMetrics, a leading innovator in pharmacy cost containment solutions, recently achieved Surescripts® Clinical Direct Messaging certification for its medication change orders. This certification enhances RazorMetrics’ ability to deliver cost-saving medication recommendations directly to prescribers’ electronic health records (EHRs), ensuring timely and secure communication.

“With Surescripts certification, we are expanding our communication capabilities to help prescribers access cost-saving recommendations within their existing workflows,” said Tom Dorsett, CEO at RazorMetrics. “By integrating with the Surescripts network, we’re providing another efficient way for providers to make informed medication decisions that support both cost savings and patient care.”

Surescripts Clinical Direct Messaging provides a secure, streamlined method for transmitting medication change orders to prescribers’ EHRs. This integration allows prescribers to receive actionable medication recommendations without disrupting their workflow.

“Surescripts is simplifying health intelligence sharing, enabling care providers with technologies like Clinical Direct Messaging that allows them to send and receive secure, HIPAA-compliant information as part of their existing workflow, so care providers can more efficiently manage time-sensitive communications and provide better informed, safer and less costly care to their patients,” said Matt Koehler, VP of Product Innovation for Surescripts. “We look forward to collaborating with RazorMetrics as part of the Surescripts Network Alliance® to empower prescribers with the information they need to make better-informed medication decisions with their patients.”

RazorMetrics’ certification ensures compliance with Surescripts’ security protocols to ensure a seamless exchange of protected health information.

With this new capability, RazorMetrics will begin transmitting change orders electronically in March 2025, with plans to scale to over 10,000 messages per month over the next six months. This milestone underscores RazorMetrics’ commitment to offering a fully integrated, multi-channel provider communication strategy, ensuring that prescribers receive cost-saving recommendations in the way that best fits their workflow.

For more information about RazorMetrics’ cost containment solutions, including medication change orders, visit razormetrics.com.

About RazorMetrics

RazorMetrics creates cutting-edge pharmacy cost containment solutions to quickly and easily reduce drug costs. Its proprietary technology automatically initiates cost-saving opportunities through medication switching, deprescription, deduplication, and more–all while adapting to fit client’s plan, preferences, and formulary. RazorMetrics conveniently plugs into prescriber’s existing workflow, improving healthcare decisions while seamlessly reducing medication costs for members and plan sponsors. Based in Austin, TX, RazorMetrics supports self-funded employers, health plans, PBMs, and organizations to bring clarity, efficiency, and more value to their pharmacy benefits. Learn more at razormetrics.com.

Media Contact
Kat Long
308.627.6897
kat.long@anthonybarnum.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/razormetrics-achieves-surescripts-clinical-direct-messaging-certification-302409784.html

SOURCE RazorMetrics

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago